NEWTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) ("Acumen" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics that ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of ...
Global nonprofit impact investor Acumen has launched a Valentine’s Day campaign urging chocolate lovers to “Make a #Cocoamitment” by choosing chocolate brands that support fair wages for cocoa farmers ...
SAN FRANCISCO, CA AND NEWTON, MA / ACCESS Newswire / July 9, 2026 / Unlearn, a pioneer of AI-powered solutions for clinical development, today announced a collaboration with Acumen Pharmaceuticals ...
IRVINE, Calif., Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the U.S. Food and ...
A few years ago, Acumen, the pioneering patient capital impact investment firm, developed a unique method for measuring impact called Lean Data. Now, it’s spinning off that approach into a separate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results